ロード中...
In vivo disruption of latent HSV by designer endonuclease therapy
A large portion of the global population carries latent herpes simplex virus (HSV), which can periodically reactivate, resulting in asymptomatic shedding or formation of ulcerative lesions. Current anti-HSV drugs do not eliminate latent virus from sensory neurons where HSV resides, and therefore do...
保存先:
| 出版年: | JCI Insight |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5026126/ https://ncbi.nlm.nih.gov/pubmed/27642635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.88468 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|